Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

David S. Ettinger; Douglas E. Wood; Dara L. Aisner; Wallace Akerley; Jessica R. Bauman; Ankit Bharat; Debora S. Bruno; Joe Y. Chang; Lucian R. Chirieac; Thomas A. D'Amico; Thomas J. Dilling; Jonathan Dowell; Scott Gettinger; Matthew A. Gubens; Aparna Hegde; Mark Hennon; Rudy P. Lackner; Michael Lanuti; Ticiana A. Leal; Jules Lin; Billy W. Loo; Christine M. Lovly; Renato G. Martins; Erminia Massarelli; Daniel Morgensztern; Thomas Ng; Gregory A. Otterson; Sandip P. Patel; Gregory J. Riely; Steven E. Schild; Theresa A. Shapiro; Aditi P. Singh; James Stevenson; Alda Tam; Jane Yanagawa; Stephen C. Yang; Kristina M. Gregory; Miranda Hughes

doi:10.6004/jnccn.2021.0013

Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Thomas J. Dilling, Jonathan Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana A. Leal, Jules LinBilly W. Loo, Christine M. Lovly, Renato G. Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes

Surgery, Thoracic Surgery Division

Research output: Contribution to journal › Review article › peer-review

688 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Original language	English (US)
Pages (from-to)	254-266
Number of pages	13
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	19
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2021.0013
State	Published - Mar 2021

Funding

This activity is supported by educational grants from Agios Pharmaceuticals; AstraZeneca; Clovis Oncology, Inc.; Daiichi Sankyo; Eisai; Epizyme Inc.; Novartis; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. This activity is supported by an independent medical education grant from Bristol-Myers Squibb, and Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is supported by an independent medical educational grant from Mylan Inc. This activity is supported by a medical education grant from Karyopharm Therapeutics. This activity is supported by an independent educational grant from AbbVie.

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2021.0013

Cite this

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., Dowell, J., Gettinger, S., Gubens, M. A., Hegde, A., Hennon, M., Lackner, R. P., Lanuti, M., Leal, T. A., ... Hughes, M. (2021). Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 19(3), 254-266. https://doi.org/10.6004/jnccn.2021.0013

@article{2a40e8dc64e147f693ce51deb5c4b840,

title = "Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.",

author = "Ettinger, {David S.} and Wood, {Douglas E.} and Aisner, {Dara L.} and Wallace Akerley and Bauman, {Jessica R.} and Ankit Bharat and Bruno, {Debora S.} and Chang, {Joe Y.} and Chirieac, {Lucian R.} and D'Amico, {Thomas A.} and Dilling, {Thomas J.} and Jonathan Dowell and Scott Gettinger and Gubens, {Matthew A.} and Aparna Hegde and Mark Hennon and Lackner, {Rudy P.} and Michael Lanuti and Leal, {Ticiana A.} and Jules Lin and Loo, {Billy W.} and Lovly, {Christine M.} and Martins, {Renato G.} and Erminia Massarelli and Daniel Morgensztern and Thomas Ng and Otterson, {Gregory A.} and Patel, {Sandip P.} and Riely, {Gregory J.} and Schild, {Steven E.} and Shapiro, {Theresa A.} and Singh, {Aditi P.} and James Stevenson and Alda Tam and Jane Yanagawa and Yang, {Stephen C.} and Gregory, {Kristina M.} and Miranda Hughes",

year = "2021",

month = mar,

doi = "10.6004/jnccn.2021.0013",

language = "English (US)",

volume = "19",

pages = "254--266",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

Ettinger, DS, Wood, DE, Aisner, DL, Akerley, W, Bauman, JR, Bharat, A, Bruno, DS, Chang, JY, Chirieac, LR, D'Amico, TA, Dilling, TJ, Dowell, J, Gettinger, S, Gubens, MA, Hegde, A, Hennon, M, Lackner, RP, Lanuti, M, Leal, TA, Lin, J, Loo, BW, Lovly, CM, Martins, RG, Massarelli, E, Morgensztern, D, Ng, T, Otterson, GA, Patel, SP, Riely, GJ, Schild, SE, Shapiro, TA, Singh, AP, Stevenson, J, Tam, A, Yanagawa, J, Yang, SC, Gregory, KM & Hughes, M 2021, 'Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 19, no. 3, pp. 254-266. https://doi.org/10.6004/jnccn.2021.0013

TY - JOUR

T1 - Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

AU - Ettinger, David S.

AU - Wood, Douglas E.

AU - Aisner, Dara L.

AU - Akerley, Wallace

AU - Bauman, Jessica R.

AU - Bharat, Ankit

AU - Bruno, Debora S.

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Dilling, Thomas J.

AU - Dowell, Jonathan

AU - Gettinger, Scott

AU - Gubens, Matthew A.

AU - Hegde, Aparna

AU - Hennon, Mark

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Leal, Ticiana A.

AU - Lin, Jules

AU - Loo, Billy W.

AU - Lovly, Christine M.

AU - Martins, Renato G.

AU - Massarelli, Erminia

AU - Morgensztern, Daniel

AU - Ng, Thomas

AU - Otterson, Gregory A.

AU - Patel, Sandip P.

AU - Riely, Gregory J.

AU - Schild, Steven E.

AU - Shapiro, Theresa A.

AU - Singh, Aditi P.

AU - Stevenson, James

AU - Tam, Alda

AU - Yanagawa, Jane

AU - Yang, Stephen C.

AU - Gregory, Kristina M.

AU - Hughes, Miranda

PY - 2021/3

Y1 - 2021/3

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=85102709190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102709190&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2021.0013

DO - 10.6004/jnccn.2021.0013

M3 - Review article

C2 - 33668021

AN - SCOPUS:85102709190

SN - 1540-1405

VL - 19

SP - 254

EP - 266

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this